Alembic Pharmaceuticals Q4 Results

  • BSE: 533573
  • NSE: APLLTD
  • ISIN: INE901L01018
  • Sector: Biotechnology & Drugs
BSE
951-1.00 (-0.11%)
Volume428.00
Updated: Thu 23 May, 2024 | 10:38:30
NSE
955.350.40 (0.04%)
Volume12.48 K
Updated: Thu 23 May, 2024 | 10:34:13
Today: 950.85
983.75
52-Wk: 536.60
1,093.05

Q4 Results Highlights

  • Total Income
    ₹1,516.98 Cr.
    (7.86%)
  • Operating Profit
    ₹190.57 Cr.
    (37.99%)
  • Profit After Tax
    ₹178.20 Cr.
    (16.79%)
  • Operating Margin
    12.56%
    (27.94%)
Note: Comparison is on YoY basis

Quarterly - Alembic Pharmaceuticals Q4 Results

*All figures in crores except per share values
Fiscal PeriodMar 24Dec 23QoQ CompMar 23YoY Comp
Total Revenue 1,516.981,630.57-6.97%1,406.457.86%
Selling/ General/ Admin Expenses Total 401.85349.2815.05%297.5735.04%
Depreciation/ Amortization 69.4869.450.04%74.12-6.26%
Other Operating Expenses Total 475.71554.16-14.16%464.162.49%
Total Operating Expense 1,326.411,433.65-7.48%1,268.354.58%
Operating Income 190.57196.92-3.22%138.1037.99%
Net Income Before Taxes 183.23184.64-0.76%124.6147.04%
Net Income 178.20180.46-1.25%152.5816.79%
Diluted Normalized EPS 9.079.18-1.20%7.7517.01%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumFor youGet App